Who owns ARS Pharmaceuticals, Inc.?
Institutional ownership of SPRY from SEC Form 13F filings across 132 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
132
13F holders
$268.3M
value, 2026 filers
36%
of shares outstanding (35.8M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of SPRY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.3M | $42.5M | 0.0% | 5.3% | +6.0% |
| 2 | Aberdeen Group plc | 4.2M | $33.4M | 0.0% | 4.2% | +1.4% |
| 3 | Capital World InvestorsNEW | 2.8M | $22.1M | 0.0% | 2.8% | new |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $20.5M | 0.0% | 2.6% | -49.8% |
| 5 | MILLENNIUM MANAGEMENT LLC | 2.4M | $19.2M | 0.0% | 2.4% | -59.9% |
| 6 | Janney Montgomery Scott LLC | 2.1M | $16,537 | 0.0% | 2.1% | +2.4% |
| 7 | UBS Group AG | 1.9M | $15.5M | 0.0% | 2% | -14.2% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $13.6M | 0.0% | 1.7% | +11.3% |
| 9 | BOOTHBAY FUND MANAGEMENT, LLC | 1.6M | $12.8M | 0.2% | 1.6% | +539.1% |
| 10 | Third Point LLC | 1.0M | $8.0M | 0.2% | 1% | 0.0% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 566,829 | $4.5M | 0.0% | 0.6% | +11.0% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 551,416 | $4.4M | 0.8% | 0.6% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551,416 | $4.4M | 0.0% | 0.6% | +3.4% |
| 14 | NORTHERN TRUST CORP | 549,064 | $4.4M | 0.0% | 0.6% | +3.7% |
| 15 | LEVIN CAPITAL STRATEGIES, L.P. | 548,965 | $4.4M | 0.3% | 0.6% | -0.7% |
| 16 | CITADEL ADVISORS LLC | 531,063 | $4.3M | 0.0% | 0.5% | -70.1% |
| 17 | BANK OF AMERICA CORP /DE/ | 463,256 | $3.7M | 0.0% | 0.5% | +62.1% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 461,384 | $3.7M | 0.0% | 0.5% | -0.7% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 461,001 | $3.7M | 0.0% | 0.5% | +3.3% |
| 20 | FIL Ltd | 455,575 | $3.6M | 0.0% | 0.5% | 0.0% |
| 21 | GOLDMAN SACHS GROUP INC | 380,770 | $3.0M | 0.0% | 0.4% | -47.4% |
| 22 | JPMORGAN CHASE & CO | 363,316 | $3.1M | 0.0% | 0.4% | -5.1% |
| 23 | FMR LLC | 349,164 | $2.8M | 0.0% | 0.4% | +2.1% |
| 24 | RAYMOND JAMES FINANCIAL INC | 318,583 | $2.6M | 0.0% | 0.3% | -39.3% |
| 25 | Jump Financial, LLCNEW | 255,200 | $2.0M | 0.0% | 0.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.